Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
05/2003
05/02/2003EP1305419A2 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof
05/02/2003EP1305404A2 Protein phosphatases
05/02/2003EP1305334A1 Urocortin proteins and uses thereof
05/02/2003EP1305330A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
05/02/2003EP1305329A1 6.alpha.,9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl)oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
05/02/2003EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
05/02/2003EP1305303A1 NOVEL FORM OF (R)- i N /i - 5-METHYL-8-(4-METHYLPIPERAZIN-1-YL)-1,2,3,4-TETRAHYDRO-2-NAPHTHYL]-4-MORPHOLINOBENZAMIDE
05/02/2003EP1305294A2 Imidazolyl derivatives
05/02/2003EP1305293A1 Hexahydro-7-imino-1h-azepin-2-yl-hexanoic acid derivatives as inhibitors of inducible nitric oxide synthase
05/02/2003EP1305046A2 Regulators of ppardelta (beta) and their use in the treatment of obesity and insulin resistance
05/02/2003EP1305017A1 Methods and compositions for the prevention and treatment of syndrome x
05/02/2003EP1221939A4 Ortho ester lipids
05/02/2003EP1093361B1 Plaster which contains steroids, and a method for the production and use thereof
05/02/2003CA2411011A1 5-heteroatom-substituted pyrazoles
05/02/2003CA2411009A1 Heterocyclo-alkylsulfonyl pyrazoles
05/02/2003CA2410364A1 5-heterocyclo-pyrazoles
05/01/2003WO2003035835A2 Glycoprotein compositions
05/01/2003WO2003035686A2 Compositions of fsh with high sialylation degree and their use for the preparation of medicaments
05/01/2003WO2003035684A1 Ee3-protein family and corresponding dna sequences
05/01/2003WO2003035668A2 Novel anti-inflammatory androstane derivatives -17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha
05/01/2003WO2003035626A2 Azole derivatives and pharmaceutical compositions containing them
05/01/2003WO2003035624A1 Quinoline compound
05/01/2003WO2003035064A1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
05/01/2003WO2003035043A2 Pharmaceutical formulation comprising more than 15% tamoxifen
05/01/2003WO2003034987A2 Androgen receptor modulators and methods of use thereof
05/01/2003WO2003008412A3 Hetero-bicyclic crf antagonists
05/01/2003WO2002102782A3 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE
05/01/2003WO2002083734A3 Modified calcitonin
05/01/2003WO2002074292A3 Hormone replacement therapy
05/01/2003WO2002039995A3 Combination therapy for estrogen-dependent disorders
05/01/2003WO2002022851A3 Novel tumor-associated marker
05/01/2003WO2002005834A3 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions
05/01/2003WO2001098346A3 Methods and compositions for the treatment of peripheral artery disease
05/01/2003US20030083337 Optically active 3-[(2-piperazinylphenyl)methyl]-1-[4-(trifluoromethyl)phenyl]-2-pyrrolidinone compounds as 5-HT1D receptor selective antagonists
05/01/2003US20030083286 Comprises penetration enhancer (fatty acid); drug delivery; increases bioavailability of oligonucleotides
05/01/2003US20030083265 TGF-beta inhibitors and methods
05/01/2003US20030083256 Compositions and methods for enhancing drug delivery across and into epithelial tissues
05/01/2003US20030083242 Methods and compositions for treating or preventing peripheral neuropathies
05/01/2003US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders
05/01/2003US20030082234 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof
05/01/2003US20030082230 Chronotherapeutic dosage forms and methods of treatment using chronotherapy
05/01/2003US20030082179 Complexing antibody with poarathyroid hormone
05/01/2003US20030079747 Method of decreasing fasting sugars and weight gains in diabetic patients
05/01/2003CA2464981A1 Quinoline compound
05/01/2003CA2464368A1 Compositions of fsh with high sialylation degree and their use for the preparation of medicaments
05/01/2003CA2464344A1 Ee3-protein family and corresponding dna sequences
05/01/2003CA2463311A1 Androgen receptor modulators and methods of use thereof
05/01/2003CA2463101A1 Azole derivatives and pharmaceutical compositions containing them
04/2003
04/30/2003CN1414941A Compound having hydroxycarbonyl-halogenoalkyl side chain
04/30/2003CN1413630A Medicine for treating over sexual intercourse, work at night, tired, poor memory, body hypoimmunity and endocrine function disturbance
04/29/2003US6555580 Treating arteriosclerosis and hypercholesterolaemia
04/29/2003US6555571 3-methyl -chromane or thiochromane derivatives
04/29/2003US6555570 Growth hormone secretagogous with improved bioavailability
04/29/2003US6555519 O-glucosylated benzamide SGLT2 inhibitors and method
04/29/2003US6555377 Process for production of mammalian cell lines
04/29/2003US6555352 Peptide for use in human therapeutics and diagnostic compositions
04/24/2003WO2003034275A2 Chimeric glycosylphosphatidylinositol containing peptides
04/24/2003WO2003034028A2 Methods for identifying and using modulators of estrogen related receptor gamma
04/24/2003WO2003033685A2 Method of producing human beta cell lines
04/24/2003WO2003033671A2 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
04/24/2003WO2003033502A1 Bicyclic oxopyridine and oxopyrimidine derivatives
04/24/2003WO2003033496A1 Beta-carbolin derivatives as ptp-inhibitors
04/24/2003WO2003033487A1 Piperidine- and piperazineacetamines as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
04/24/2003WO2003033461A1 Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens
04/24/2003WO2003033010A1 Cyclosporin analogs for the treatment of autoimmune diseases
04/24/2003WO2003032991A1 N-aroyl piperazine derivatives as orexin receptor antagonists
04/24/2003WO2003032982A1 Bis-heteroaryl alkanes as therapeutic agents
04/24/2003WO2003032965A2 Use of ace inhibitors for reducing type 2 diabetes in high risk patients
04/24/2003WO2003032963A2 Method of reducing type 2 diabetes in high risk patients
04/24/2003WO2003032918A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors
04/24/2003WO2003032910A2 Carbinols for the treatment of neuropathic dysfunction
04/24/2003WO2002085921A3 Simple method for the synthesis of boswellic acids and derivatives thereof
04/24/2003WO2002066018A3 Transdermal therapeutic system containing testosterone and method for the production thereof
04/24/2003WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003WO2002024180A3 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia
04/24/2003US20030078289 Indole carboxylic acids as thyroid receptor ligands
04/24/2003US20030078288 Indole derivatives
04/24/2003US20030078275 For therapy of cancer, diabetes and Alzheimer's disease
04/24/2003US20030078270 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
04/24/2003US20030078260 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
04/24/2003US20030078244 Regulation of intracellular glucocorticoid concentrations
04/24/2003US20030078214 Phytooestrogen selected from genistein, daidzein; for promoting health in cases of cancer, pre-menstrual syndrome, menopause or hypercholesterolaemia
04/24/2003US20030078166 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003US20030077638 MID 4460, a human tyrosine phosphatase family member and uses therefor
04/24/2003US20030077313 Anti-stress composition intended for incorporation mainly in nutritional vehicles
04/24/2003US20030077291 Active enamel matrix substance, such as an amelogenin, a processed amelogenin product, or a metabolite can be used in treating conditions in a mammal which present an imbalance in its native immune resposne to external or internal stimuli
04/24/2003US20030077280 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated T cells and thereby inhibits T cell activation of B cells
04/24/2003US20030077273 Methods of treating antibody-mediated pathologies using agents which inhibit CD21
04/24/2003US20030077256 Pancreas regeneration using embryonic pancreatic cells
04/24/2003CA2494706A1 Chimeric glycosylphosphatidylinositol containing peptides
04/24/2003CA2464435A1 Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens
04/24/2003CA2463979A1 Method of producing human beta cell lines
04/24/2003CA2463908A1 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
04/24/2003CA2463729A1 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors
04/24/2003CA2463682A1 Method of reducing type 2 diabetes in high risk patients
04/24/2003CA2463518A1 Carbinols for the treatment of neuropathic dysfunction
04/24/2003CA2462147A1 Bicyclic oxopyridine and oxopyrimidine derivatives
04/23/2003EP1304324A1 Serotonin reuptake inhibitors
04/23/2003EP1304113A1 Isolated stromal cells and methods of using the same
04/23/2003EP1304112A1 Isolated stromal cells and methods of using the same
1 ... 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 ... 290